WESTBROOK, Maine, Jan. 23, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), has scheduled the release of its 2013 fourth quarter and full-year financial results for Tuesday, February 4, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
Individuals can access a live webcast of the conference call through a link on the IDEXX website, http://www.idexx.com. An archived edition of the call will be available after 1:00 p.m. ET on that day via the same link.
The live call also will be accessible by telephone. To listen to the live conference call, please dial 877-209-9922 or 612-332-0932 and reference confirmation code 317200. Replay of the conference call will be available through Tuesday, February 11, by dialing 320-365-3844 and referencing replay code 317200.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 5,500 people and offers products to customers in over 175 countries.
Note Regarding Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available from the SEC's EDGAR database at www.sec.gov, at various SEC reference facilities in the United States and via the Company's website at www.idexx.com).
Contact: Bonnie Reid, Investor Relations, 1-207-556-8155
SOURCE IDEXX Laboratories, Inc.